tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AstraZeneca’s Fasenra approved in U.S. to treat adults with EGPA
The FlyAstraZeneca’s Fasenra approved in U.S. to treat adults with EGPA
15h ago
AZN
AstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
PremiumCompany Announcements
AstraZeneca’s Fasenra Wins FDA Approval for Rare Vasculitis
18h ago
AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit
PremiumThe Fly
AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit
3d ago
AZN
AstraZeneca announces updated results from HIMALAYA Phase III trial of Imjudo
PremiumThe Fly
AstraZeneca announces updated results from HIMALAYA Phase III trial of Imjudo
3d ago
AZN
AstraZeneca Chair Shows Confidence with Share Purchase
PremiumCompany Announcements
AstraZeneca Chair Shows Confidence with Share Purchase
5d ago
AstraZeneca says ENHERTU achieved 61.6% progression-free survival rate in study
PremiumThe FlyAstraZeneca says ENHERTU achieved 61.6% progression-free survival rate in study
5d ago
AZN
Deutsche downgrades AstraZeneca to Sell on challenging risk/reward
Premium
The Fly
Deutsche downgrades AstraZeneca to Sell on challenging risk/reward
6d ago
AZN
AstraZeneca downgraded to Sell from Hold at Deutsche Bank
Premium
The Fly
AstraZeneca downgraded to Sell from Hold at Deutsche Bank
6d ago
AZN
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
7d ago
AR
MS
Erste upgrades AstraZeneca to Buy on strong oncology sales growth
PremiumThe Fly
Erste upgrades AstraZeneca to Buy on strong oncology sales growth
8d ago
AZN
AstraZeneca upgraded to Buy from Hold at Erste Group
PremiumThe Fly
AstraZeneca upgraded to Buy from Hold at Erste Group
8d ago
AZN
AstraZeneca downgraded to Sell from Hold at Nordea
PremiumThe Fly
AstraZeneca downgraded to Sell from Hold at Nordea
8d ago
AZN
AstraZeneca Shares Fall on Lung Cancer Drug Trial’s Outcome
PremiumMarket NewsAstraZeneca Shares Fall on Lung Cancer Drug Trial’s Outcome
8d ago
AZN
Sophia Genetics announces collaboration agreement with AstraZeneca
Premium
The Fly
Sophia Genetics announces collaboration agreement with AstraZeneca
8d ago
AZN
SOPH
J&J Rybrevant/Lazcluze study shows superiority over lazertinib for NSCLC
Premium
The Fly
J&J Rybrevant/Lazcluze study shows superiority over lazertinib for NSCLC
9d ago
AZN
JNJ
AstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
PremiumThe Fly
AstraZeneca says Dato-DXd showed clinically meaningful trend toward improving OS
9d ago
AZN
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
9d ago
AZN
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
PremiumThe Fly
Innate Pharma reports AstraZeneca presentation of results from NeoCOAST-2 study
10d ago
AZN
IPHA
Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz
PremiumThe Fly
Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz
13d ago
AI
BA
Five AstraZeneca employees under investigation in China, Bloomberg reports
PremiumThe FlyFive AstraZeneca employees under investigation in China, Bloomberg reports
14d ago
AZN
C4 Therapeutics appoints Stephen Fawell to board of directors
Premium
The Fly
C4 Therapeutics appoints Stephen Fawell to board of directors
16d ago
AZN
CCCC
AstraZeneca Shares and Voting Rights Update
Premium
Company Announcements
AstraZeneca Shares and Voting Rights Update
16d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >